Arrowstreet Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $447M | Buy |
6,219,756
+1,899,932
| +44% | +$146M | 0.24% | 88 |
|
|
2025
Q4 | $343M | Sell |
4,319,824
-974,310
| -18% | -$76.8M | 0.2% | 113 |
|
|
2025
Q3 | $399M | Buy |
5,294,134
+2,188,307
| +70% | +$150M | 0.25% | 79 |
|
|
2025
Q2 | $214M | Buy |
3,105,827
+1,878,217
| +153% | +$123M | 0.15% | 131 |
|
|
2025
Q1 | $83.2M | Buy |
1,227,610
+1,044,465
| +570% | +$62.5M | 0.07% | 265 |
|
|
2024
Q4 | $8.22M | Sell |
183,145
-2,867,351
| -94% | -$161M | 0.01% | 878 |
|
|
2024
Q3 | $192M | Buy |
3,050,496
+1,229,230
| +67% | +$71.7M | 0.16% | 117 |
|
|
2024
Q2 | $108M | Buy |
1,821,266
+1,186,148
| +187% | +$74.2M | 0.09% | 180 |
|
|
2024
Q1 | $50.7M | Buy |
+635,118
| New | +$48.5M | 0.05% | 309 |
|
|
2023
Q4 | – | Sell |
-16,119
| Closed | -$1.13M | – | 1433 |
|
|
2023
Q3 | $1.13M | Sell |
16,119
-933,366
| -98% | -$66.1M | ﹤0.01% | 959 |
|
|
2023
Q2 | $65.6M | Buy |
949,485
+285,503
| +43% | +$20.3M | 0.08% | 206 |
|
|
2023
Q1 | $49.3M | Buy |
663,982
+610,883
| +1,150% | +$51.2M | 0.06% | 271 |
|
|
2022
Q4 | $4.95M | Buy |
+53,099
| New | +$5.12M | 0.01% | 682 |
|
|
2022
Q3 | – | Sell |
-870,507
| Closed | -$80.7M | – | 1306 |
|
|
2022
Q2 | $80.7M | Buy |
870,507
+154,470
| +22% | +$15.1M | 0.11% | 167 |
|
|
2022
Q1 | $72.5M | Buy |
716,037
+696,429
| +3,552% | +$73.2M | 0.09% | 209 |
|
|
2021
Q4 | $2.02M | Buy |
+19,608
| New | +$1.81M | ﹤0.01% | 1019 |
|
|
2021
Q2 | – | Sell |
-222,072
| Closed | -$16.7M | – | 1945 |
|
|
2021
Q1 | $16.7M | Buy |
+222,072
| New | +$16.2M | 0.02% | 664 |
|
|
2020
Q4 | – | Sell |
-298,606
| Closed | -$17.4M | – | 2330 |
|
|
2020
Q3 | $17.4M | Buy |
298,606
+272,097
| +1,026% | +$16.9M | 0.03% | 610 |
|
|
2020
Q2 | $1.72M | Sell |
26,509
-568,724
| -96% | -$35.8M | ﹤0.01% | 1542 |
|
|
2020
Q1 | $35.3M | Buy |
+595,233
| New | +$39.7M | 0.1% | 186 |
|
|
2019
Q3 | – | Sell |
-13,400
| Closed | -$730K | – | 1563 |
|
|
2019
Q2 | $730K | Sell |
13,400
-9,900
| -42% | -$533K | ﹤0.01% | 1127 |
|
|
2019
Q1 | $1.26M | Buy |
23,300
+6,000
| +35% | +$370K | ﹤0.01% | 1256 |
|
|
2018
Q4 | $1.13M | Buy |
+17,300
| New | +$1.29M | ﹤0.01% | 924 |
|
|
2018
Q3 | – | Sell |
-6,812
| Closed | -$438K | – | 1121 |
|
|
2018
Q2 | $438K | Sell |
6,812
-1,983,572
| -100% | -$131M | ﹤0.01% | 933 |
|
|
2018
Q1 | $124M | Sell |
1,990,384
-4,880,780
| -71% | -$350M | 0.28% | 93 |
|
|
2017
Q4 | $498M | Buy |
6,871,164
+6,777,364
| +7,225% | +$493M | 1.2% | 13 |
|
|
2017
Q3 | $7.63M | Sell |
93,800
-159,008
| -63% | -$12.6M | 0.02% | 417 |
|
|
2017
Q2 | $20.3M | Sell |
252,808
-2,365,148
| -90% | -$187M | 0.06% | 249 |
|
|
2017
Q1 | $206M | Buy |
+2,617,956
| New | +$209M | 0.75% | 26 |
|
|
2016
Q4 | – | Sell |
-259,364
| Closed | -$23.1M | – | 1823 |
|
|
2016
Q3 | $23.1M | Sell |
259,364
-819,580
| -76% | -$77.4M | 0.08% | 260 |
|
|
2016
Q2 | $103M | Buy |
1,078,944
+197,238
| +22% | +$19.7M | 0.34% | 82 |
|
|
2016
Q1 | $91.5M | Sell |
881,706
-1,446,214
| -62% | -$141M | 0.39% | 56 |
|
|
2015
Q4 | $228M | Buy |
2,327,920
+170,437
| +8% | +$16.7M | 1.05% | 17 |
|
|
2015
Q3 | $208M | Buy |
2,157,483
+1,178,665
| +120% | +$124M | 0.99% | 19 |
|
|
2015
Q2 | $103M | Sell |
978,818
-711,189
| -42% | -$72.7M | 0.58% | 43 |
|
|
2015
Q1 | $174M | Buy |
1,690,007
+595,769
| +54% | +$60.3M | 1.07% | 17 |
|
|
2014
Q4 | $105M | Buy |
1,094,238
+561,354
| +105% | +$49.5M | 0.6% | 37 |
|
|
2014
Q3 | $42.4M | Buy |
532,884
+390,782
| +275% | +$30.8M | 0.23% | 113 |
|
|
2014
Q2 | $10.7M | Sell |
142,102
-976,266
| -87% | -$73.8M | 0.06% | 287 |
|
|
2014
Q1 | $83.7M | Buy |
+1,118,368
| New | +$79M | 0.51% | 47 |
|
|
2013
Q4 | – | Sell |
-679,392
| Closed | -$38.6M | – | 1171 |
|
|
2013
Q3 | $38.6M | Buy |
679,392
+359,262
| +112% | +$21.4M | 0.25% | 107 |
|
|
2013
Q2 | $18.3M | Buy |
+320,130
| New | +$18.5M | 0.14% | 156 |
|
Other funds holding CVS
VCM
VPM
Arrowstreet Capital's CVS Position: Q1 2026 in Review
Arrowstreet Capital increased its CVS Health (CVS) stake by 44% in Q1 2026, buying an estimated $146M and bringing the position to 6,219,756 shares worth $447M. The position accounts for 0.24% of the portfolio, ranked #88.
Arrowstreet Capital first reported a position in CVS in Q2 2013 and has held it in 42 quarters since. The position peaked at $498M in Q4 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Arrowstreet Capital held 6,219,756 shares of CVS Health worth $447M as of Q1 2026.
- Arrowstreet Capital bought 1,899,932 CVS Health shares in Q1 2026, an estimated $146M.
- CVS Health made up 0.24% of Arrowstreet Capital's portfolio in Q1 2026, its #88 holding.
- Arrowstreet Capital first reported a position in CVS Health in Q2 2013 and has held it in 42 quarters since.
- Arrowstreet Capital's CVS Health position peaked at $498M in Q4 2017.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.